Overview

Low Dose Ketamine Intra Nasal Traumatology

Status:
Completed

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of early administration of low-dose intranasal ketamine analgesic agents in patients with moderate to severe pain in the ED in reducing the need for opioid or non opioids analgesic agents.

Phase:

Phase 2

Details

Lead Sponsor:

University of Monastir

Treatments:

Ketamine